Literature DB >> 1347052

A method of preparing blood leucocytes for flow cytometry which prevents upregulation of leucocyte integrins.

A Hamblin1, M Taylor, J Bernhagen, Z Shakoor, S Mayall, G Noble, D McCarthy.   

Abstract

LeuCAM (CD11/CD18) cell-surface antigens are easily upregulated on cell manipulation ex vivo. A procedure for preparing leucocytes, in which human blood is immediately treated ex vivo with buffered formaldehyde and then the erythrocytes and platelets are removed by lysis and differential centrifugation, has been successfully applied to the analysis of LeuCAM antigen expression by flow cytometry. We show that the increased expression of monocyte CD11/CD18, which occurs when mononuclear leucocytes are separated by a standard Lymphoprep density gradient separation, can be avoided if cells are fixed immediately. Following this fixation polymorphs are unable to upregulate CD11/CD18 in response to fMLP stimulation in vitro. The technique produces lymphocyte, polymorph and monocyte populations that can be clearly defined on the basis of forward scatter and side scatter, and preserves the expression of various surface antigens; the percentages of gated lymphocytes expressing CD3, CD4, and CD8 were similar to those obtained using a commercial fixing and lysis solution. The processing does not render cells permeable to antibodies, as evidenced by our failure to stain cells with antibodies to intracellular antigens. We believed the method to be useful for measuring CD11/CD18 expression on blood leucocytes from normal or pathological specimens and to have application to the measurement of other cells surface antigens which may also be upregulated by the separation procedures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347052     DOI: 10.1016/0022-1759(92)90231-h

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  28 in total

1.  Primed PMNs in healthy mouse and human circulation are first responders during acute inflammation.

Authors:  Noah Fine; Oriyah Barzilay; Chunxiang Sun; Nimali Wellappuli; Farzeen Tanwir; Jeffrey W Chadwick; Morvarid Oveisi; Nikola Tasevski; David Prescott; Martin Gargan; Dana J Philpott; Yigal Dror; Michael Glogauer
Journal:  Blood Adv       Date:  2019-05-28

2.  Use of buffered formaldehyde in the enzymatic digestion of inflamed mucosa.

Authors:  J Meenan; D O Obradov; H van Dullemen; G N Tytgat; S J van Deventer
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Role of chemotactic factors in neutrophil activation after thermal injury in rats.

Authors:  M T Piccolo; Y Wang; S Verbrugge; R L Warner; P Sannomiya; N S Piccolo; M S Piccolo; T E Hugli; P A Ward; G O Till
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

4.  Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.

Authors:  R A Janssen; A A Heijn; T H The; L de Leij
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

5.  Increased CD11/CD18 expression on the peripheral blood leucocytes of patients with HIV disease: relationship to disease severity.

Authors:  S Palmer; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Increased CD11/CD18 expression on peripheral blood leucocytes of patients with sarcoidosis.

Authors:  Z Shakoor; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

7.  Rapid cytokine up-regulation of integrins, complement receptor 1 and HLA-DR on monocytes but not on lymphocytes.

Authors:  G A Limb; A S Hamblin; R A Wolstencroft; D C Dumonde
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

8.  Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?

Authors:  A C Muller Kobold; G Mesander; C A Stegeman; C G Kallenberg; J W Tervaert
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

9.  Inhibition of leucocyte adhesion molecule upregulation by tumor necrosis factor alpha: a novel mechanism of action of sulphasalazine.

Authors:  S M Greenfield; A S Hamblin; Z S Shakoor; J P Teare; N A Punchard; R P Thompson
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

10.  Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose.

Authors:  P A Palmer; J G Scharenberg; B M von Blomberg; A G Stam; C J Meijer; G J Roest; C R Franks; R J Scheper
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.